Does empiric treatment with fluoroquinolones delay the diagnosis of tuberculosis in patients with hemodialysis?

Hemodialysis International

Volumn 12, Issue 4, 2008, Pages 499-500

  Osawa, Norihisa ^a   Sakaguchi, Masayoshi ^a   Sugimoto, Toshiro ^a   Isshiki, Keiji ^a   Kanasaki, Masami ^a   Nishio, Toshiki ^b   Uzu, Takashi ^a   Kashiwagi, Atsunori ^a   Okada, Yusaku ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b Medical Care Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CIPROFLOXACIN; ETHAMBUTOL; GALLIUM; ISONIAZID; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ADULT; ANAMNESIS; BACTERIAL INFECTION; CASE REPORT; DELAYED DIAGNOSIS; DIABETIC NEUROPATHY; DRUG EFFICACY; FEVER; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYDRONEPHROSIS; INFLAMMATION; LETTER; LYMPHADENOPATHY; MALE; MYCOBACTERIUM TUBERCULOSIS; PROGNOSIS; TREATMENT DURATION; TUBERCULOSIS; WEGENER GRANULOMATOSIS;

ANTI-BACTERIAL AGENTS; FEVER OF UNKNOWN ORIGIN; FLUOROQUINOLONES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TUBERCULOSIS, PULMONARY;

EID: 53549124134     PISSN: 14927535     EISSN: 15424758     Source Type: Journal    
DOI: 10.1111/j.1542-4758.2008.00314.x     Document Type: Letter

References (3)

1. Abderahman M, Sinha AK, Karkar A. Tuberculosis in end-stage renal disease patients on hemodialysis. Hemodial Int. 2006; 10: 360-364.
2. Sasaki S, Akiba T, Suenaga M, et al. Ten years' survey of dialysis-associated tuberculosis. Nephron. 1979; 24: 141-145.
3. Wang J-Y, Hsueh R-R, Jan I-S, et al. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax. 2006; 61: 903-980.